Proactive Investors - Run By Investors For Investors

ANGLE plc has "major breakthrough" for Parsortix

Andrew Newland, CEO of ANGLE plc (LON:AGL), tells Proactiveinvestors that the company has achieved a "major breakthrough" in the potential use of its Parsortix non-invasive cancer diagnostic product. Andrew discusses what it means for the company and what investors should now watch out for.
Meet Caledonia Mining, OPG Power Ventures, Range Resources and Jersey Oil & Gas at our event, London, 03 December 2015. Register here »
Why Invest In ANGLE plc? Read More Here

Register here to be notified of future ANGLE plc articles
View full AGL profile

ANGLE plc Timeline

July 23 2015

© Proactive Investors 2015

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.